Erratum

In the original article by Han, et al., entitled “MicroRNA-873 Promotes Cell Proliferation, Migration, and Invasion by Directly Targeting TSLC1 in Hepatocellular Carcinoma” [Cell Physiol Biochem 2018;46(6):2261-2270, DOI: 10.1159/000489594], Fig. 2 and 5 contain misplaced subfigures (2D and 5C). The correct Fig. 2 and 5 are displayed below.
The authors confirm that all of the results and conclusions of the article remain unchanged, as well as the figure legends.

The authors sincerely apologize for this mistake.

Fig. 2. The effects of miRNA-873 inhibition on cell growth, migration, and invasion by the HCC cell line HepG2. (A) Real-time PCR was used to measure miRNA-873 expression levels after transfection with an miRNA-873 inhibitor or negative control vector. (B) A CCK-8 assay was used to show the effect of miRNA- 873 inhibition on the HepG2 cell proliferation rate. (C) Flow cytometry was used to show the effect of miRNA-873 inhibition on the HepG2 cell cycle. (D) Transwell assay was used to show the effect of miRNA- 873 inhibition on HepG2 migration and invasion. *P<0.05, **P<0.01.

Fig. 5. The effect of TSLC1 overexpression on miRNA-873-mediated HCC progression. (A and B) Cell proliferation and the cell cycle were assessed in Huh7 cells transfected with miRNA-873 with and without TSLC1 overexpression. (C) Cell migration and invasion were determined in Huh7 cells transfected with miRNA-873 with and without TSLC1 overexpression. *P<0.05, ***P<0.01.